CNS & Neurological Disorders - Drug Targets
Title:Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)]
Volume: 11 Issue: 3
Author(s): Francesco Papaleo
Affiliation:
Export Options
About this article
Cite this article as:
Papaleo Francesco, Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)], CNS & Neurological Disorders - Drug Targets 2012; 11 (3) . https://dx.doi.org/10.2174/187152712800672508
DOI https://dx.doi.org/10.2174/187152712800672508 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Erlotinib in Glioblastoma - Lost in Translation?
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Genus <i>Pongamia</i> and <i>Derris</i>: Phytochemical and Bioactivity
Mini-Reviews in Medicinal Chemistry TRP Channels in the Digestive System
Current Pharmaceutical Biotechnology Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces
Current Medicinal Chemistry Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Bradykinin B2 receptors play a neuroprotective role in Hypoxia/reoxygenation injury related to pyroptosis pathway
Current Neurovascular Research The Association of <i>CYP2D6*4</i> and <i>POR*28</i> Polymorphisms on Mirtazapine Plasma Level in Subjects with Major Depressive Disorder and Anxiety Disorders
Combinatorial Chemistry & High Throughput Screening Chondroitin Sulfate and Sulfur Containing Chondroprotective Agents: Is there a Basis for their Pharmacological Action?
Current Rheumatology Reviews Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Cannabinoid System on Immune Modulation: Therapeutic Implications on CNS Inflammation
Mini-Reviews in Medicinal Chemistry Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review
Current Pharmaceutical Design Neuregulin Signaling in Pieces-Evolution of the Gene Family
Current Pharmaceutical Design Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Current Pharmaceutical Biotechnology CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Hexokinase and VDAC in Neurological Disorders
Current Molecular Pharmacology Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders Neuroproteomics and the Detection of Regulatory Phosphosites
Current Proteomics Clinical Trajectories and Biological Features of Primary Progressive Aphasia (PPA)
Current Alzheimer Research Clinical Implications of Patient-Provider Agreements in Opioid Prescribing
Current Drug Safety